Sarcoidosis: Epidemiology, Etiology, Pathogenesis, and Genetics

Disease-a-Month

Volumn 55, Issue 11, 2009, Pages 649-660

  Lazarus, Angeline ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA A1 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B27 ANTIGEN; HLA B8 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INORGANIC COMPOUND; INTERLEUKIN 1BETA; SODIUM CHLORIDE;

AGE DISTRIBUTION; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CYTOKINE PRODUCTION; DIAGNOSTIC TEST; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; ETHNIC DIFFERENCE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC PREDISPOSITION; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INCIDENCE; LUNG SARCOIDOSIS; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MORBIDITY; MYCOBACTERIUM TUBERCULOSIS; OCCUPATIONAL EXPOSURE; PREVALENCE; PROGNOSIS; PROPIONIBACTERIUM ACNES; REVIEW; RISK ASSESSMENT; RISK FACTOR; SARCOIDOSIS; SEX DIFFERENCE;

CYTOKINES; ENVIRONMENTAL EXPOSURE; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFECTION; SARCOIDOSIS;

EID: 70350141023     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2009.04.008     Document Type: Review

References (47)

1. Sharma O. Sarcoidosis: A historical perspective. Clin Dermatol 25 (2007) 232-241
2. Statement on Sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160 (1999) 736-755
3. Rybicki B.A., Major M., Popovich Jr. J., et al. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol 145 (1997) 234-241
4. Chen E.S., and Moller D.R. Etiology of sarcoidosis. Clin Chest Med 29 (2008) 365-377
5. Iannuzzi M.C., Rybicki B.A., and Teirstein A.S. Sarcoidosis. N Engl J Med 357 (2007) 2153-2165
6. Nagai S., and Izumi T. Pulmonary sarcoidosis: Population differences and pathophysiology. South Med J 88 (1995) 1001-1010
7. Milman N., and Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1981: Epidemiology and clinical picture. Sarcoidosis 7 (1990) 50-57
8. Milman N., and Hoffmann A.L. Childhood sarcoidosis: Long-term follow up. Eur Respir J 31 (2008) 592-598
9. Fauroux B., and Clément A. Pediatric sarcoidosis. Pædiatr Respir Rev 6 (2005) 128-133
10. Sharma O.P. Sarcoidosis around the world. Clin Chest Med 29 (2008) 357-363
11. Iwai K., Sekiguti M., Hosoda Y., et al. Racial difference in cardiac sarcoidosis observed at autopsy. Sarcoidosis 11 (1994) 26-31
12. Sharma S.K., and Mohan A. Sarcoidosis: Global scenario and Indian perspective. Indian J Med Res 116 (2002) 221-247
13. Newman L.S., Rose C.S., Bresnitz E.A., et al. A case control etiologic study of sarcoidosis: Environmental and occupational risk factors. Am J Respir Crit Care Med 170 (2004) 1324-1330
14. Barnard J., Rose C., Newman L., et al. Job and industry classifications associated with sarcoidosis in a case control etiologic study of sarcoidosis (ACCESS). J Occup Environ Med 47 (2005) 226-234
15. Song Z., Marzilli L., Greenlee B.M., et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoid. J Exp Med 201 (2005) 721-767 [Published erratum in J Exp Med 2005;202:72]
16. Drake W.P., Dhason M.S., Nadaf M., et al. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun 75 (2007) 527-530
17. Klemen H., Husain A.N., Cagle P.T., et al. Mycobacterial DNA in recurrent sarcoidosis in the transplanted lung: A PCR-based study on four cases. Virchows Arch 436 (2000) 365-369
18. Gupta D., Agarwal R., Agarwal A.N., et al. Molecular evidence for the role of mycobacteria in sarcoidosis: A meta-analysis. Eur Respir J 30 (2007) 508-516
19. Eishi Y., Suga M., Ishige I., et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymphnodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 40 (2002) 198-204
20. Hiramatsu J., Kataoka M., Nakata Y., et al. Propionibacterium acnes DNA detected in bronchoalveolar lavage cells from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 20 (2003) 197-203
21. Bachelez H., Senet P., Cadranel J., et al. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137 (2001) 69-73
22. Ishige I., Eishi Y., Takemura T., et al. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22 (2005) 33-42
23. Heyll A., Meckenstock G., Aul C., et al. Possible transmission of sarcoidosis via allogenic bone marrow transplantation. Bone Marrow Transplant 14 (1994) 161-164
24. Izbicki G., Chavko R., Banauch G.I., et al. World Trade Center "sarcoid-like" granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest 131 (2007) 1414-1423
25. Ma Y., Gal A., and Koss M.N. The pathology of pulmonary sarcoidosis: Update. Semin Diagn Pathol 24 (2007) 150-161
26. Gerke A.K., and Hunninghake G. The immunology of sarcoidosis. Clin Chest Med 29 (2008) 379-390
27. Hunninghake G.W., Gadek J.E., Young R.C., et al. Maintenance of granuloma formation in pulmonary sarcoidosis by T-lymphocytes within the lung. N Engl J Med 302 (1980) 594-598
28. Agostini C., Adami F., and Semenzato G. New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol 12 (2000) 71-76
29. + T cells in sarcoidosis. Proc Am Thorac Soc 4 (2007) 461-462
30. h1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 156 (1996) 4952-4960
31. Girgis R.E., Basha M.A., Maliaril M., et al. Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis. Am J Respir Crit Care Med 152 (1995) 71
32. Shigehara K., Shijubo N., Ohmichi M., et al. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 166 (2001) 642-649
33. Mathew S., Bauer K.L., Fischoeder A., et al. The anergic state in sarcoidosis is associated with diminished dendritic cell function. J Immunol 181 (2008) 746-755
34. Siltzback L.E. The Kveim test in sarcoidosis: A study of 750 patients. J Am Med Assoc 178 (1961) 476-482
35. Judson M.A., Hirst K., Iyengar S.K., et al. Comparison of sarcoidosis phenotypes among affected African-American siblings. Chest 130 (2006) 855-862
36. Grunewald J., Ekland A., and Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 169 (2004) 696-702
37. Martinetti M., Tinelli C., Kolek V., et al. "The sarcoidosis map": A joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 152 (1995) 557-564
38. Iannuzzi M.J., Maliarik M.J., Poisson L.M., et al. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med 167 (2003) 1225-1231
39. Rossman M.D., Thompson B., Frederick M., et al. HLA-DRB* 1101: A significant factor for sarcoidosis in blacks and whites. Am J Hum Genet 73 (2003) 720-735
40. Rybicki B.A., Maliarik M.J., Poisson L.M., et al. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am J Respir Crit Care Med 167 (2003) 444-449
41. Rutherford R.M., Brutsche M.H., Kearns M., et al. HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 21 (2004) 191-198
42. Iannuzzi M.C., and Rybicki B.A. Genetics of sarcoidosis. Proc Am Thorac Soc 4 (2007) 108-116
43. Schürmann M., Reichel P., Müller-Myhsok B., et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 164 (2001) 840-846
44. Iannuzzi M.C., Iyengar S.K., Gray-McGuire C., et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 6 (2005) 509-518
45. Müller-Quernheim J., Schürmann M., Hofmann S., et al. Genetics of sarcoidosis. Clin Chest Med 29 (2008) 391-414
46. Gray-McGuire C., Sinha R., Iyengar S.K., et al. Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5. Hum Genet 120 (2006) 420-430
47. Grunewald J., and Eklund A. Löfgren's syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 179 (2009) 307-312